Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Recepteur d’Origine Nantais (RON), also known as MST1R, is a receptor tyrosine kinase belonging to the MET proto-oncogene family. It is a heterodimeric protein activated by its ligand, Macrophage Stimulating Protein (MSP), leading to downstream signaling through pathways like PI3K/AKT and MAPK, influencing cell growth, survival, and inflammation. RON is implicated in cancer progression and metastasis, making it a therapeutic target of interest.
Tyrosine kinase inhibition (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Recepteur d’Origine Nantais (RON).